Skip to main content
Erschienen in: Journal of Neurology 9/2023

09.06.2023 | Original Communication

Risk and protective factors in Parkinson's disease: a simultaneous and prospective study with classical statistical and novel machine learning models

verfasst von: Alessandro Gialluisi, Maria Ilenia De Bartolo, Simona Costanzo, Daniele Belvisi, Stefania Falciglia, Moreno Ricci, Augusto Di Castelnuovo, Teresa Panzera, Maria Benedetta Donati, Giovanni Fabbrini, Giovanni de Gaetano, Alfredo Berardelli, Licia Iacoviello

Erschienen in: Journal of Neurology | Ausgabe 9/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Several environmental/lifestyle factors have been individually investigated in previous Parkinson’s disease (PD) studies with controversial results. No study has prospectively and simultaneously investigated potential risk/protective factors of PD using both classical statistical and novel machine learning analyses. The latter may reveal more complex associations and new factors that are undetected by merely linear models. To fill this gap, we simultaneously investigated potential risk/protective factors involved in PD in a large prospective population study using both approaches.

Methods

Participants in the Moli-sani study were enrolled between 2005 and 2010 and followed up until December 2018. Incident PD cases were identified by individual-level record linkage to regional hospital discharge forms, the Italian death registry, and the regional prescription register. Exposure to potential risk/protective factors was assessed at baseline. Multivariable Cox Proportional Hazards (PH) regression models and survival random forests (SRF) were built to identify the most influential factors.

Results

We identified 213 incident PD cases out of 23,901 subjects. Cox PH models revealed that age, sex, dysthyroidism and diabetes were associated with an increased risk of PD. Both hyper and hypothyroidism were independently associated with PD risk. SRF showed that age was the most influential factor in PD risk, followed by coffee intake, daily physical activity, and hypertension.

Conclusion

This study sheds light on the role of dysthyroidism, diabetes and hypertension in PD onset, characterized to date by an uncertain relationship with PD, and also confirms the relevance of most factors (age, sex, coffee intake, daily physical activity) reportedly shown be associated with PD. Further methodological developments in SRF models will allow to untangle the nature of the potential non-linear relationships identified.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Ascherio A, Schwarzschild MA (2016) The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol 15:1257–1272CrossRefPubMed Ascherio A, Schwarzschild MA (2016) The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol 15:1257–1272CrossRefPubMed
3.
Zurück zum Zitat Belvisi D, Pellicciari R, Fabbrini A, Costanzo M, Pietracupa S, De Lucia M et al (2020) Risk factors of Parkinson disease: simultaneous assessment, interactions, and etiologic subtypes. Neurology 95:e2500–e2508CrossRefPubMedPubMedCentral Belvisi D, Pellicciari R, Fabbrini A, Costanzo M, Pietracupa S, De Lucia M et al (2020) Risk factors of Parkinson disease: simultaneous assessment, interactions, and etiologic subtypes. Neurology 95:e2500–e2508CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Belvisi D, Pellicciari R, Fabbrini G, Tinazzi M, Berardelli A, Defazio G (2020) Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson’s disease: What do prospective studies suggest? Neurobiol Dis 134:104671CrossRefPubMed Belvisi D, Pellicciari R, Fabbrini G, Tinazzi M, Berardelli A, Defazio G (2020) Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson’s disease: What do prospective studies suggest? Neurobiol Dis 134:104671CrossRefPubMed
5.
Zurück zum Zitat Chen Y, Sun X, Lin Y, Zhang Z, Gao Y, Wu IXY (2021) Non-genetic risk factors for Parkinson’s disease: an overview of 46 systematic reviews. J Parkinsons Dis 11:919–935CrossRefPubMedPubMedCentral Chen Y, Sun X, Lin Y, Zhang Z, Gao Y, Wu IXY (2021) Non-genetic risk factors for Parkinson’s disease: an overview of 46 systematic reviews. J Parkinsons Dis 11:919–935CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32:S498-504CrossRefPubMed Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32:S498-504CrossRefPubMed
7.
Zurück zum Zitat Pisani P, Faggiano F, Krogh V, Palli D, Vineis P, Berrino F (1997) Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol 26(Suppl 1):S152-160CrossRefPubMed Pisani P, Faggiano F, Krogh V, Palli D, Vineis P, Berrino F (1997) Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol 26(Suppl 1):S152-160CrossRefPubMed
8.
Zurück zum Zitat Pala V, Sieri S, Palli D, Salvini S, Berrino F, Bellegotti M et al (2003) Diet in the Italian EPIC cohorts: presentation of data and methodological issues. Tumori 89:594–607CrossRefPubMed Pala V, Sieri S, Palli D, Salvini S, Berrino F, Bellegotti M et al (2003) Diet in the Italian EPIC cohorts: presentation of data and methodological issues. Tumori 89:594–607CrossRefPubMed
9.
Zurück zum Zitat Ruggiero E, Di Castelnuovo A, Costanzo S, Persichillo M, De Curtis A, Cerletti C et al (2021) Daily coffee drinking is associated with lower risks of cardiovascular and total mortality in a general Italian population: results from the Moli-sani study. J Nutr 151:395–404CrossRefPubMed Ruggiero E, Di Castelnuovo A, Costanzo S, Persichillo M, De Curtis A, Cerletti C et al (2021) Daily coffee drinking is associated with lower risks of cardiovascular and total mortality in a general Italian population: results from the Moli-sani study. J Nutr 151:395–404CrossRefPubMed
10.
Zurück zum Zitat Shi Y, Zhang K, Ye M (2021) Well-water consumption and risk of Parkinson’s disease: a meta-analysis of 15 observational studies. Neuropsychiatr Dis Treat 17:3705–3714CrossRefPubMedPubMedCentral Shi Y, Zhang K, Ye M (2021) Well-water consumption and risk of Parkinson’s disease: a meta-analysis of 15 observational studies. Neuropsychiatr Dis Treat 17:3705–3714CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Bonaccio M, Di Castelnuovo A, Costanzo S, De Lucia F, Olivieri M, Donati MB et al (2013) Nutrition knowledge is associated with higher adherence to Mediterranean diet and lower prevalence of obesity. Results from the Moli-sani study. Appetite 68:139–146CrossRefPubMed Bonaccio M, Di Castelnuovo A, Costanzo S, De Lucia F, Olivieri M, Donati MB et al (2013) Nutrition knowledge is associated with higher adherence to Mediterranean diet and lower prevalence of obesity. Results from the Moli-sani study. Appetite 68:139–146CrossRefPubMed
12.
Zurück zum Zitat Chen S-F, Yang Y-C, Hsu C-Y, Shen Y-C (2020) Risk of Parkinson’s disease in patients with hypothyroidism: a nationwide population-based cohort study. Parkinsonism Relat Disord 74:28–32CrossRefPubMed Chen S-F, Yang Y-C, Hsu C-Y, Shen Y-C (2020) Risk of Parkinson’s disease in patients with hypothyroidism: a nationwide population-based cohort study. Parkinsonism Relat Disord 74:28–32CrossRefPubMed
13.
Zurück zum Zitat Lin S-R, Chen S-F, Yang Y-C, Hsu C-Y, Shen Y-C (2020) Association between hyperthyroidism and risk of incident in Parkinson’s disease. Endocr Connect 10:13–20CrossRefPubMedCentral Lin S-R, Chen S-F, Yang Y-C, Hsu C-Y, Shen Y-C (2020) Association between hyperthyroidism and risk of incident in Parkinson’s disease. Endocr Connect 10:13–20CrossRefPubMedCentral
14.
Zurück zum Zitat Cho YY, Kim B, Shin DW, Youn J, Mok JO, Kim C-H et al (2022) Graves’ disease and the risk of Parkinson’s disease: a Korean population-based study. Brain Commun 4:fcac014CrossRefPubMedPubMedCentral Cho YY, Kim B, Shin DW, Youn J, Mok JO, Kim C-H et al (2022) Graves’ disease and the risk of Parkinson’s disease: a Korean population-based study. Brain Commun 4:fcac014CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Mohammadi S, Dolatshahi M, Rahmani F (2021) Shedding light on thyroid hormone disorders and Parkinson disease pathology: mechanisms and risk factors. J Endocrinol Invest 44:1–13CrossRefPubMed Mohammadi S, Dolatshahi M, Rahmani F (2021) Shedding light on thyroid hormone disorders and Parkinson disease pathology: mechanisms and risk factors. J Endocrinol Invest 44:1–13CrossRefPubMed
17.
Zurück zum Zitat Powers KM, Smith-Weller T, Franklin GM, Longstreth WT, Swanson PD, Checkoway H (2006) Diabetes, smoking, and other medical conditions in relation to Parkinson’s disease risk. Parkinsonism Relat Disord 12:185–189CrossRefPubMed Powers KM, Smith-Weller T, Franklin GM, Longstreth WT, Swanson PD, Checkoway H (2006) Diabetes, smoking, and other medical conditions in relation to Parkinson’s disease risk. Parkinsonism Relat Disord 12:185–189CrossRefPubMed
18.
Zurück zum Zitat D’Amelio M, Ragonese P, Callari G, Di Benedetto N, Palmeri B, Terruso V et al (2009) Diabetes preceding Parkinson’s disease onset. A case-control study. Parkinsonism Relat Disord 15:660–664CrossRefPubMed D’Amelio M, Ragonese P, Callari G, Di Benedetto N, Palmeri B, Terruso V et al (2009) Diabetes preceding Parkinson’s disease onset. A case-control study. Parkinsonism Relat Disord 15:660–664CrossRefPubMed
19.
Zurück zum Zitat Savica R, Grossardt BR, Ahlskog JE, Rocca WA (2012) Metabolic markers or conditions preceding Parkinson’s disease: a case-control study. Mov Disord 27:974–979CrossRefPubMedPubMedCentral Savica R, Grossardt BR, Ahlskog JE, Rocca WA (2012) Metabolic markers or conditions preceding Parkinson’s disease: a case-control study. Mov Disord 27:974–979CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Palacios N, Gao X, McCullough ML, Jacobs EJ, Patel AV, Mayo T et al (2011) Obesity, diabetes, and risk of Parkinson’s disease. Mov Disord 26:2253–2259CrossRefPubMedPubMedCentral Palacios N, Gao X, McCullough ML, Jacobs EJ, Patel AV, Mayo T et al (2011) Obesity, diabetes, and risk of Parkinson’s disease. Mov Disord 26:2253–2259CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat De Pablo-Fernandez E, Goldacre R, Pakpoor J, Noyce AJ, Warner TT (2018) Association between diabetes and subsequent Parkinson disease: a record-linkage cohort study. Neurology 91:e139–e142CrossRefPubMed De Pablo-Fernandez E, Goldacre R, Pakpoor J, Noyce AJ, Warner TT (2018) Association between diabetes and subsequent Parkinson disease: a record-linkage cohort study. Neurology 91:e139–e142CrossRefPubMed
22.
Zurück zum Zitat Jeong S-M, Han K, Kim D, Rhee SY, Jang W, Shin DW (2020) Body mass index, diabetes, and the risk of Parkinson’s disease. Mov Disord 35:236–244CrossRefPubMed Jeong S-M, Han K, Kim D, Rhee SY, Jang W, Shin DW (2020) Body mass index, diabetes, and the risk of Parkinson’s disease. Mov Disord 35:236–244CrossRefPubMed
23.
Zurück zum Zitat Heinzel S, Berg D, Gasser T, Chen H, Yao C, Postuma RB et al (2019) Update of the MDS research criteria for prodromal Parkinson’s disease. Mov Disord 34:1464–1470CrossRefPubMed Heinzel S, Berg D, Gasser T, Chen H, Yao C, Postuma RB et al (2019) Update of the MDS research criteria for prodromal Parkinson’s disease. Mov Disord 34:1464–1470CrossRefPubMed
24.
Zurück zum Zitat Cheong JLY, de Pablo-Fernandez E, Foltynie T, Noyce AJ (2020) The association between Type 2 diabetes Mellitus and Parkinson’s disease. J Parkinsons Dis 10:775–789CrossRefPubMedPubMedCentral Cheong JLY, de Pablo-Fernandez E, Foltynie T, Noyce AJ (2020) The association between Type 2 diabetes Mellitus and Parkinson’s disease. J Parkinsons Dis 10:775–789CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Xu K, Di Luca DG, Orrú M, Xu Y, Chen J-F, Schwarzschild MA (2016) Neuroprotection by caffeine in the MPTP model of Parkinson’s disease and its dependence on adenosine A2A receptors. Neuroscience 322:129–137CrossRefPubMed Xu K, Di Luca DG, Orrú M, Xu Y, Chen J-F, Schwarzschild MA (2016) Neuroprotection by caffeine in the MPTP model of Parkinson’s disease and its dependence on adenosine A2A receptors. Neuroscience 322:129–137CrossRefPubMed
27.
Zurück zum Zitat Yang F, Trolle Lagerros Y, Bellocco R, Adami H-O, Fang F, Pedersen NL et al (2015) Physical activity and risk of Parkinson’s disease in the Swedish National March Cohort. Brain 138:269–275CrossRefPubMed Yang F, Trolle Lagerros Y, Bellocco R, Adami H-O, Fang F, Pedersen NL et al (2015) Physical activity and risk of Parkinson’s disease in the Swedish National March Cohort. Brain 138:269–275CrossRefPubMed
28.
Zurück zum Zitat Xu Q, Park Y, Huang X, Hollenbeck A, Blair A, Schatzkin A et al (2010) Physical activities and future risk of Parkinson disease. Neurology 75:341–348CrossRefPubMedPubMedCentral Xu Q, Park Y, Huang X, Hollenbeck A, Blair A, Schatzkin A et al (2010) Physical activities and future risk of Parkinson disease. Neurology 75:341–348CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Chen H, Zhang SM, Schwarzschild MA, Hernán MA, Ascherio A (2005) Physical activity and the risk of Parkinson disease. Neurology 64:664–669CrossRefPubMed Chen H, Zhang SM, Schwarzschild MA, Hernán MA, Ascherio A (2005) Physical activity and the risk of Parkinson disease. Neurology 64:664–669CrossRefPubMed
30.
Zurück zum Zitat Thacker EL, Chen H, Patel AV, McCullough ML, Calle EE, Thun MJ et al (2008) Recreational physical activity and risk of Parkinson’s disease. Mov Disord 23:69–74CrossRefPubMedPubMedCentral Thacker EL, Chen H, Patel AV, McCullough ML, Calle EE, Thun MJ et al (2008) Recreational physical activity and risk of Parkinson’s disease. Mov Disord 23:69–74CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Tajiri N, Yasuhara T, Shingo T, Kondo A, Yuan W, Kadota T et al (2010) Exercise exerts neuroprotective effects on Parkinson’s disease model of rats. Brain Res 1310:200–207CrossRefPubMed Tajiri N, Yasuhara T, Shingo T, Kondo A, Yuan W, Kadota T et al (2010) Exercise exerts neuroprotective effects on Parkinson’s disease model of rats. Brain Res 1310:200–207CrossRefPubMed
32.
Zurück zum Zitat Chen J, Zhang C, Wu Y, Zhang D (2019) Association between hypertension and the risk of Parkinson’s disease: a meta-analysis of analytical studies. Neuroepidemiology 52:181–192CrossRefPubMed Chen J, Zhang C, Wu Y, Zhang D (2019) Association between hypertension and the risk of Parkinson’s disease: a meta-analysis of analytical studies. Neuroepidemiology 52:181–192CrossRefPubMed
33.
Zurück zum Zitat Loftus AM, Gasson N, Lopez N, Sellner M, Reid C, Cocks N et al (2021) Cognitive reserve, executive function, and memory in Parkinson’s disease. Brain Sci 11:992CrossRefPubMedPubMedCentral Loftus AM, Gasson N, Lopez N, Sellner M, Reid C, Cocks N et al (2021) Cognitive reserve, executive function, and memory in Parkinson’s disease. Brain Sci 11:992CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Sieurin J, Andel R, Tillander A, Valdes EG, Pedersen NL, Wirdefeldt K (2018) Occupational stress and risk for Parkinson’s disease: a nationwide cohort study. Mov Disord 33:1456–1464CrossRefPubMedPubMedCentral Sieurin J, Andel R, Tillander A, Valdes EG, Pedersen NL, Wirdefeldt K (2018) Occupational stress and risk for Parkinson’s disease: a nationwide cohort study. Mov Disord 33:1456–1464CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Darweesh SKL, Vermeulen R, Bloem BR, Peters S (2022) Exposure to pesticides predicts prodromal feature of Parkinson’s disease: public health implications. Mov Disord 37:883–885CrossRefPubMed Darweesh SKL, Vermeulen R, Bloem BR, Peters S (2022) Exposure to pesticides predicts prodromal feature of Parkinson’s disease: public health implications. Mov Disord 37:883–885CrossRefPubMed
36.
Zurück zum Zitat Boulos C, Yaghi N, El Hayeck R, Heraoui GN, Fakhoury-Sayegh N (2019) Nutritional risk factors, microbiota and Parkinson’s disease: What is the current evidence? Nutrients 11:E1896CrossRef Boulos C, Yaghi N, El Hayeck R, Heraoui GN, Fakhoury-Sayegh N (2019) Nutritional risk factors, microbiota and Parkinson’s disease: What is the current evidence? Nutrients 11:E1896CrossRef
37.
Zurück zum Zitat Checkoway H, Franklin GM, Costa-Mallen P, Smith-Weller T, Dilley J, Swanson PD et al (1998) A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson’s disease. Neurology 50:1458–1461CrossRefPubMed Checkoway H, Franklin GM, Costa-Mallen P, Smith-Weller T, Dilley J, Swanson PD et al (1998) A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson’s disease. Neurology 50:1458–1461CrossRefPubMed
38.
Zurück zum Zitat Eusebi P, Franchini D, De Giorgi M, Abraha I, Montedori A, Casucci P et al (2019) Incidence and prevalence of Parkinson’s disease in the Italian region of Umbria: a population-based study using healthcare administrative databases. Neurol Sci 40:1709–1712CrossRefPubMed Eusebi P, Franchini D, De Giorgi M, Abraha I, Montedori A, Casucci P et al (2019) Incidence and prevalence of Parkinson’s disease in the Italian region of Umbria: a population-based study using healthcare administrative databases. Neurol Sci 40:1709–1712CrossRefPubMed
39.
Zurück zum Zitat Valent F, Devigili G, Rinaldo S, Del Zotto S, Tullio A, Eleopra R (2018) The epidemiology of Parkinson’s disease in the Italian region Friuli Venezia Giulia: a population-based study with administrative data. Neurol Sci 39:699–704CrossRefPubMed Valent F, Devigili G, Rinaldo S, Del Zotto S, Tullio A, Eleopra R (2018) The epidemiology of Parkinson’s disease in the Italian region Friuli Venezia Giulia: a population-based study with administrative data. Neurol Sci 39:699–704CrossRefPubMed
Metadaten
Titel
Risk and protective factors in Parkinson's disease: a simultaneous and prospective study with classical statistical and novel machine learning models
verfasst von
Alessandro Gialluisi
Maria Ilenia De Bartolo
Simona Costanzo
Daniele Belvisi
Stefania Falciglia
Moreno Ricci
Augusto Di Castelnuovo
Teresa Panzera
Maria Benedetta Donati
Giovanni Fabbrini
Giovanni de Gaetano
Alfredo Berardelli
Licia Iacoviello
Publikationsdatum
09.06.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 9/2023
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-023-11803-1

Weitere Artikel der Ausgabe 9/2023

Journal of Neurology 9/2023 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.